Sertraline and Nadroparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordNadroparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You're taking sertraline (an antidepressant) along with nadroparin, a blood thinner given by injection. Both can make it harder for your blood to clot. Sertraline affects tiny blood cells called platelets that help stop bleeding, and nadroparin thins the blood directly. Put together, they can raise your chance of bleeding or bruising.
Watch for things like nosebleeds, easy bruising, small red spots on the skin, or bleeding that won't stop. Serious bleeding is rare but possible. Please don't stop either medicine on your own. Your care team knows how to handle this by keeping a closer eye on you, and they can answer any questions you have.
Effect: Additive increase in bleeding risk with concurrent sertraline and nadroparin (a low molecular weight heparin).
Mechanism: SSRIs deplete platelet serotonin, impairing platelet-mediated hemostasis; this is additive to nadroparin's anticoagulant (anti-Xa) effect. This is a pharmacodynamic interaction, not a CYP-mediated one.
- Direction: increased bleeding risk (additive)
- Onset: delayed
- Evidence: probable (case-control/cohort data)
- Severity: major
Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, and signs of major hemorrhage. Counsel the patient on bleeding risk. Dosing and monitoring should be individualized by the care team.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and advise them of the elevated bleeding risk.1. Hemostasis depends in part on the platelet-mediated release of serotonin. Studies using case-control and cohort designs have demonstrated that using SSRIs (for example, sertraline) alongside anticoagulants carries an association with greater bleeding risk 231. Taking sertraline at the same time as an anticoagulant may increase the likelihood of bleeding. Among the bleeding events that have been documented are epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
The good news is your care team can manage this combination safely.
- Keep taking both as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely for bleeding while you use these together.
- Watch for and report nosebleeds, unusual bruising, small red skin spots, dark or bloody stools, pink or red urine, or bleeding that won't stop.
- Get urgent help for severe or uncontrolled bleeding.
Ask your pharmacist or prescriber about anything else that thins your blood, including aspirin, NSAIDs like ibuprofen, or supplements, so your team can tailor your plan.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a heightened risk of clinically relevant bleeding (hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also on SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched with randomly chosen patients who received warfarin alone (n=117). The SSRIs used were FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. Nine patients had 11 bleeding episodes over 213.9 treatment years in the warfarin plus SSRI group, whereas 10 patients had 14 bleedings over 586.4 treatment years in the warfarin-only group. The respective total bleeding incidences were 51.4 and 23.9 per 1000 treatment years. The hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009) relative to warfarin alone. In patients who bled during concomitant administration, the SSRI involved was sertraline or citalopram. Adding an SSRI was not linked to a change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be limited by prior bleeding events, unknown patient adherence, and the exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants other than warfarin from the model 2.
b) A population-based, case-controlled study of new coumarin users (acenocoumarol and phenprocoumon) taking selective serotonin reuptake inhibitors (SSRIs) at the same time found a raised risk of hospitalization for non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them with 5818 control subjects who were also on a coumarin. The median treatment duration in patients was 220 days (range, 1 to 4690 days). Patients using SSRIs had greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial of 12 healthy volunteers, the influence of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or placebo group; sertraline was titrated upward from 50 mg/day to 200 mg/day. Prothrombin time was measured before each warfarin dose and at intervals afterward. The investigators concluded that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown an association between the use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, exposure to SSRIs, especially in the month prior to delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage. Bleeding events linked to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Nadroparin together?
Using sertraline with the blood thinner nadroparin can add up to a higher bleeding risk, so keep taking both as prescribed but watch for bruising or bleeding and report it to your care team. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Nadroparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Nadroparin interaction managed?
The good news is your care team can manage this combination safely. Keep taking both as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for bleeding while you use these together. Watch for and report nosebleeds, unusual bruising, small red skin spots, dark or bloody stools, pink or red urine, or bleeding that won't stop. Get urgent help for severe or u… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Nadroparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Nadroparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist